Answers are grounded in this paper and cite their sources.
Purpose. The evaluated the use of lymph node ratio (LNR) as a prognostic predictor for patients with stage Ⅲ colorectal cancer. Materials and Methods. We retrospectively and consecutively reviewed the records of 109 colorectal cancer patients who had received curative resection at Veteran General Hospital Kaohsiung (VGHKS) between January 1998 to December 2002. Lymph node (LN) disease was diagnosed and staged into quartiles according criteria established by the American Joint Committee on Cancer. Survival was calculated by Kaplan-Meier analysis and was assessed by the log rank test. The lymph node ratio was calculated by dividing the number of disease positive lymph nodes with the total number of resected nodes, both variables previously reported to be of independent prognostic importance. Result. Eight hundred eighty-four patients were diagnosed with colorectal cancer in our hospital between 1998 and 2002. We selected 109 patients with stage Ⅲ disease. Seventy-three (67%) were men and 36 women (33%) with median age was 63 years (range 27 to 86). In each patient, a minimum of 10 LNs were harvested. We found a significant difference in overall survival among the four groups analyzed by LN ratio quartiles: group 1 had an LNR less than 0.25; group 2, 0.25-0.5; group 3, 0.5-0.75; and group 4, 0.75-1.0.) The 5-year survival rate of those in group 1 was 75% but for those in group 4, it was 23% (P<0.007). Conclusion. This study suggests that LNR can be used as a potent predictor of survival for patients with stage Ⅲ colorectal carcinoma.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: